Recruiting

Observational Study

Sponsor:

Massachusetts General Hospital

Code:

NCT01126788

Conditions

Peripheral Arterial Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This study is designed to test two hypotheses:

1. The PADnet+ testing system produces clinically equivalent results as the Parks Flo-Lab testing system in a group of patients referred for evaluation of PAD of the limbs when performed by a Registered Vascular Technologist (RVT).
2. The PADnet+ testing system produces clinically equivalent results when the testing is repeated on the above patients and performed by staff specifically trained on the use of the PADnet+ system but are not vascular technologists nor hold the RVT certification.

Conditions

Peripheral Arterial Disease

Study ID

NCT01126788

Start date

Dec, 2009

Status verified date

Nov, 2010

Completion date

Dec, 2011

Anticipated

Primary completion date

Dec, 2011

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • All patients referred to the MGH Vascular Labs for diagnostic testing for PAD

Exclusion Criteria:

  • None

Study Design

Enrollment

100 participants

Anticipated

Interventions and Outcome Measures

Arms

PADnet + testing

Parks Flo-lab Test

Central Contacts and Locations

Locations

Massachsetts General Hospital

Recruiting

Boston, Massachusetts, United States, 02114

Contacts

Principal Investigator:

Glenn LaMuraglia, MD

More Information

Sponsor

Massachusetts General Hospital

Last update posted

Nov 24, 2010

Last verified

Nov, 2010

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2010-11-24.